The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma.
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; BMS Oncology; Sanofi
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bausch and Lomb (I); Bristol-Myers Squibb; CG Oncology; Ferring; Janssen Oncology; Johnson & Johnson; Olympus; pacific edge; Pfizer; Photocure; Protara Therapeutics; QED Therapeutics
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Janssen Oncology; Photocure
 
Yu Che
No Relationships to Disclose
 
David A. Pfister
No Relationships to Disclose
 
Pia Paffenholz
Honoraria - BMS GmbH & Co. KG; Eisai; Janssen; Merck
Consulting or Advisory Role - Janssen; Merck; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
Alireza Ghoreifi
No Relationships to Disclose
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer
 
Marcus Hentrich
Consulting or Advisory Role - Amgen; BeiGene; Bristol Myers Squibb Germany; Eusa Pharma; Janssen-Cilag; Merck; Oncopeptides; Sanofi; Stemline Therapeutics
Speakers' Bureau - Amgen; Gilead Sciences; Janssen-Cilag; Recordati; Sanofi
Travel, Accommodations, Expenses - Gilead Sciences; Janssen-Cilag; Jazz Pharmaceuticals; Merck
 
Sophia Thy
No Relationships to Disclose
 
Peter Albers
Consulting or Advisory Role - Ferring
 
Clint Cary
No Relationships to Disclose
 
Axel Gerdtsson
No Relationships to Disclose
 
Anders Kjellman
No Relationships to Disclose
 
Helene F. S. Negaard
No Relationships to Disclose